Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

Historical Holders from Q1 2014 to Q3 2025

Symbol: ITCI
Type / Class: Equity / Common Stock, $0.0001 Par Value Per Share
Shares outstanding: 107,800,271
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 1
Holdings value: $2,540
Number of holders: 1
Number of sells: -3
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
FMR LLC	2.5%		$355,390,543		2,695,006		FMR LLC	31 Jan 2025

Institutional Holders of Intra-Cellular Therapies, Inc. - Common Stock, $0.0001 Par Value Per Share (ITCI)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	1	$2,540	-$4,151,955			$2,540	1
2025 Q2	52,839	$4,154,495	-$12,449,682,474	$0	$0	$105.26	4
2025 Q1	95,162,616	$12,552,502,929	+$921,696,752	$245,477,512	$295,579,512	$131.92	392
2024 Q4	96,744,219	$8,079,865,976	-$54,744,614	$8,752,640	$23,669,340	$83.52	377
2024 Q3	97,160,903	$7,121,640,397	+$61,346,999	$10,464,818	$23,283,760	$73.17	353
2024 Q2	96,602,103	$6,617,629,592	+$540,380,977	$19,656,630	$21,115,467	$68.49	373
2024 Q1	88,802,162	$6,144,405,843	-$32,018,043	$75,428,000	$60,550,000	$69.2	340
2023 Q4	89,563,791	$6,415,135,392	+$224,593,251	$21,285,464	$50,055,218	$71.62	328
2023 Q3	87,179,976	$4,544,446,834	+$123,461,814	$10,782,630	$10,470,090	$52.09	291
2023 Q2	84,403,188	$5,343,315,732	+$44,821,938	$9,485,336	$14,057,040	$63.32	285
2023 Q1	83,859,451	$4,542,535,552	+$27,528,728	$11,042,830	$39,173,550	$54.15	270
2022 Q4	83,443,197	$4,415,758,766	-$3,028,583	$11,515,296	$13,822,308	$52.92	281
2022 Q3	83,532,103	$3,886,674,923	+$66,690,194	$9,817,000	$13,387,000	$46.53	259
2022 Q2	81,474,793	$4,652,094,119	+$43,593,822	$16,393,000	$18,441,000	$57.08	255
2022 Q1	80,764,803	$4,938,561,645	+$733,231,750	$14,749,000	$26,212,000	$61.19	233
2021 Q4	68,372,935	$3,578,473,075	+$18,800,232	$29,054,000	$59,690,000	$52.34	200
2021 Q3	68,588,515	$2,557,003,664	+$56,527,997	$6,137,000	$26,750,000	$37.28	175
2021 Q2	66,978,934	$2,733,829,933	-$33,681,490	$9,972,000	$35,179,000	$40.82	182
2021 Q1	67,974,787	$2,304,237,493	+$32,399,854	$16,687,000	$20,623,000	$33.93	164
2020 Q4	67,139,548	$2,135,092,569	+$100,905,848	$18,357,000	$23,544,000	$31.8	176
2020 Q3	63,785,787	$1,634,885,756	+$385,137,060	$24,357,000	$32,691,000	$25.66	174
2020 Q2	48,754,610	$1,251,468,595	+$59,105,576	$30,130,000	$79,899,000	$25.67	146
2020 Q1	47,153,491	$724,899,165	+$133,197,856	$6,305,000	$9,594,000	$15.37	136
2019 Q4	38,034,445	$1,304,492,153	-$41,694,110	$473,794,009	$217,451,343	$34.31	133
2019 Q3	39,826,397	$297,543,953	-$2,558,157	$16,958,000	$13,630,000	$7.47	124
2019 Q2	38,368,267	$497,297,783	+$34,719,274	$16,601,000	$44,614,227	$12.98	125
2019 Q1	38,349,415	$467,093,056	+$6,914,203	$4,039,000	$38,920,000	$12.18	125
2018 Q4	37,911,631	$431,767,392	-$15,478,031	$10,068,000	$40,164,000	$11.39	125
2018 Q3	38,097,172	$826,730,269	-$21,276,548	$23,745,000	$46,587,000	$21.7	131
2018 Q2	39,155,084	$692,047,361	-$3,733,399	$14,852,000	$33,441,000	$17.67	127
2018 Q1	39,402,764	$829,283,428	+$31,390,253	$15,467,000	$27,948,000	$21.05	129
2017 Q4	38,248,685	$553,055,977	-$43,016,176	$4,199,000	$10,199,200	$14.48	129
2017 Q3	40,538,909	$639,569,213	+$156,289,362	$11,312,000	$6,536,000	$15.78	136
2017 Q2	30,949,779	$384,461,374	+$12,666,882	$883,000	$6,662,000	$12.42	99
2017 Q1	29,318,781	$476,437,910	+$46,854,550	$2,306,000	$3,939,000	$16.25	113
2016 Q4	30,132,601	$454,629,539	+$33,366,992	$1,556,000	$3,253,000	$15.09	127
2016 Q3	27,893,149	$424,898,393	-$109,128,726	$12,239,000	$12,894,000	$15.24	127
2016 Q2	30,535,006	$1,185,218,083	+$46,613,508	$6,163,000	$13,835,000	$38.82	139
2016 Q1	29,397,909	$817,105,887	+$7,113,194	$4,951,000	$1,098,000	$27.8	125
2015 Q4	28,527,256	$1,534,595,286	+$39,089,907	$10,834,000	$4,217,000	$53.79	131
2015 Q3	27,866,362	$1,115,757,230	+$395,309,998	$14,466,000	$14,000,000	$40.04	128
2015 Q2	18,074,357	$577,471,946	+$34,573,785	$1,294,000	$2,412,000	$31.95	91
2015 Q1	16,955,478	$404,896,238	+$111,856,653			$23.88	74
2014 Q4	12,215,655	$215,606,755	+$2,355,713			$17.65	47
2014 Q3	12,095,621	$165,831,275	-$574,655			$13.71	48
2014 Q2	12,087,115	$203,786,729	+$17,674,093			$16.86	55
2014 Q1	11,038,114	$200,671,000	+$200,671,000			$18.18	35